4.5 Article

Utility of functional diffusion maps to monitor a patient diagnosed with gliomatosis cerebri

Journal

JOURNAL OF NEURO-ONCOLOGY
Volume 97, Issue 3, Pages 419-423

Publisher

SPRINGER
DOI: 10.1007/s11060-009-0018-y

Keywords

Gliomatosis cerebri; Functional diffusion maps; Diffusion MRI; Non-enhancing glioma; Cancer biomarkers

Funding

  1. National Institutes of Health and National Cancer Institute (NIH/NCI) [R21 CA109820]
  2. MCW Translational Brain Tumor Program
  3. Advancing a Healthier Wisconsin
  4. MCW Cancer Center

Ask authors/readers for more resources

Diffusion-weighted magnetic resonance imaging (DWI) is a sensitive imaging biomarker for tumor cellularity. Functional diffusion maps (fDMs), which examine voxel-by-voxel changes in the apparent diffusion coefficient (ADC) calculated from serial DWIs, have previously been applied to regions of contrast-enhancement; however, application of fDMs to non-enhancing brain tumors has not been pursued. In this case study we demonstrate the utility of applying fDMs to regions of abnormal FLAIR signal intensity in a patient diagnosed with gliomatosis cerebri: a relatively rare, infiltrative, non-enhancing brain tumor. The absolute volume of hypercellularity extracted from fDMs was useful in tracking tumor growth, which correlated in time with a progressive decline in neurological status despite no change in traditional magnetic resonance images. Results of this study demonstrate the value of fDMs, applied to regions of FLAIR abnormal signal intensity, for localizing regions of hypercellularity and for monitoring overall tumor status.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available